VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the de...

Full description

Saved in:
Bibliographic Details
Main Authors Kenney, Matthew, Kannan, Vinayagam
Format Patent
LanguageEnglish
Published 15.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
AbstractList Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
Author Kenney, Matthew
Kannan, Vinayagam
Author_xml – fullname: Kenney, Matthew
– fullname: Kannan, Vinayagam
BookMark eNrjYmDJy89L5WSwCXMM9g8Icg0O9vRTcPMP8g31cQzx9PcLBnEUQoNdFYDiIUGujiG-rn4hCv5uCh6RAf4hrn7BQEU8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwNDC2MjU0sLY0dCYOFUABw8s2w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID US2018325983A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2018325983A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:17:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2018325983A13
Notes Application Number: US201816044078
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181115&DB=EPODOC&CC=US&NR=2018325983A1
ParticipantIDs epo_espacenet_US2018325983A1
PublicationCentury 2000
PublicationDate 20181115
PublicationDateYYYYMMDD 2018-11-15
PublicationDate_xml – month: 11
  year: 2018
  text: 20181115
  day: 15
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies Par Pharmaceutical, Inc
RelatedCompanies_xml – name: Par Pharmaceutical, Inc
Score 3.180505
Snippet Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Title VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181115&DB=EPODOC&locale=&CC=US&NR=2018325983A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rS8MwED_GfH7TqUydUlD6rZitT8EhWx9MsQ_WdsxPo2kjCNINW_Hf9xI73ad9y13gSAL3Su5-AbjNM70gBTGVe7MgipYbmkL7eq5khOZqNmCkEHAMfmBMUu15rs9b8LHuhRE4od8CHBE1Kkd9r4W9Xv1fYjmitrK6o-_IWj56ydCRm-wY3RVGOLIzHrpR6IS2bNvDNJaDqZhTMdS31BHmSjs8kOZI--5szPtSVptOxTuC3QjllfUxtFjZgQN7_fdaB_b95sm7A3uiRjOvkNnoYXUCD7NRHIrDewokzOP89OW3H5gTUhq7EvKTqTtKOFa_FHrS5DUKEzfgpvMUbjw3sScKLmjxt_9FGm-uXj2DdrksWRekzLAMyorBm0otzVKLTCc41JhlZoxQRs6ht03SxfbpSzjkJG-86-s9aNefX-wKPXBNr8XB_QAxJIS0
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KPeqbVsWjakDJW3DbnIJB2hyk2iSlSUp9KtlkBUHSYiP-fSdrqn3q2-4MDLMLc3y7O7MAd1mq5iQnuvSg50RSMk2RaFfNpJTQTE57jOS8HYMfaF6iPM_UWQM-1rUwvE_oN2-OiBaVob2X3F8v_w-xbP62cnVP35G0eHJj0xZrdIzhCjMc0R6Yzji0Q0u0LDOJxGDCeTKm-obcR6y0oyMo5GBpOqjqUpabQcU9hN0xyivKI2iwog0ta_33Whv2_frKuw17_I1mtkJibYerY3ic9qOQb94wEBDH-cnotx64mghJ5AhIjydOP6569QuhK3iv4zB2gsp1nsCt68SWJ6FC87_1z5NoU3v5FJrFomBnIKSaoVGW995kaiiGnKcqwaHCDD1lhDJyDp1tki62s2-g5cX-aD4aBi-XcFCxqiK8rtqBZvn5xa4wGpf0mm_iD4qmh54
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=VASOPRESSIN+FORMULATIONS+FOR+USE+IN+TREATMENT+OF+HYPOTENSION&rft.inventor=Kenney%2C+Matthew&rft.inventor=Kannan%2C+Vinayagam&rft.date=2018-11-15&rft.externalDBID=A1&rft.externalDocID=US2018325983A1